Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists

Takhyeon Kweon, Yerim Kim, Kyung Joo Lee, Won-Woo Seo, Seung In Seo, Woon Geon Shin, Dong Ho Shin · 2023

Read Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists by Takhyeon Kweon, Yerim Kim, Kyung Joo Lee, Won-Woo Seo, Seung In Seo, Woon Geon Shin, Dong Ho Shin (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10689439.txt.

Description

Takhyeon Kweon and co-authors weigh two kinds of stomach drugs against kidney risk in a 2023 study. One kind, taken by vast numbers for heartburn and ulcers, had been linked in past work to long-term kidney loss. The other kind is an older rival drug used for the same ills.

The team mined a national health sample and records from six hospitals, matching like patients across drug groups. Rates of new kidney loss came out much the same for both drugs. A pooled check across the hospital sets showed no clear added risk for the first drug. The results calm one fear, though such record studies cannot end the debate.

Catalog record

CREATORTakhyeon Kweon, Yerim Kim, Kyung Joo Lee, Won-Woo Seo, Seung In Seo, Woon Geon Shin, Dong Ho Shin
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10689439

Browse the full library · About the Tower of Babel